Geode Capital Management LLC Buys 69,851 Shares of Stryker Corporation $SYK

Geode Capital Management LLC grew its stake in shares of Stryker Corporation (NYSE:SYK) by 0.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 7,535,572 shares of the medical technology company’s stock after buying an additional 69,851 shares during the period. Geode Capital Management LLC’s holdings in Stryker were worth $2,636,238,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of SYK. United Financial Planning Group LLC bought a new position in shares of Stryker in the third quarter worth approximately $27,000. CGC Financial Services LLC bought a new position in shares of Stryker in the fourth quarter worth approximately $29,000. Strive Asset Management LLC bought a new position in shares of Stryker in the third quarter worth approximately $30,000. ANTIPODES PARTNERS Ltd purchased a new stake in Stryker in the third quarter worth approximately $34,000. Finally, Ares Financial Consulting LLC purchased a new stake in Stryker in the fourth quarter worth approximately $40,000. 77.09% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several analysts have issued reports on the company. JPMorgan Chase & Co. cut their target price on Stryker from $445.00 to $400.00 and set an “overweight” rating for the company in a research note on Friday, May 1st. William Blair reaffirmed an “outperform” rating on shares of Stryker in a research note on Thursday, March 5th. Weiss Ratings lowered Stryker from a “hold (c+)” rating to a “hold (c)” rating in a research note on Monday, May 4th. Deutsche Bank Aktiengesellschaft set a $315.00 target price on Stryker in a research note on Friday, May 1st. Finally, Needham & Company LLC cut their target price on Stryker from $454.00 to $418.00 and set a “buy” rating for the company in a research note on Friday, May 1st. Sixteen investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $395.48.

Insider Buying and Selling at Stryker

In other news, VP M Kathryn Fink sold 3,500 shares of the stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $283.45, for a total transaction of $992,075.00. Following the completion of the sale, the vice president owned 177 shares of the company’s stock, valued at approximately $50,170.65. This represents a 95.19% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 4.60% of the company’s stock.

Stryker Stock Performance

NYSE:SYK opened at $306.16 on Thursday. The firm has a market cap of $117.37 billion, a PE ratio of 35.44, a price-to-earnings-growth ratio of 1.97 and a beta of 0.80. Stryker Corporation has a fifty-two week low of $281.00 and a fifty-two week high of $404.87. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.25 and a current ratio of 2.11. The business has a 50 day moving average price of $323.45 and a 200-day moving average price of $348.79.

Stryker (NYSE:SYK) last released its quarterly earnings data on Thursday, April 30th. The medical technology company reported $2.60 earnings per share for the quarter, missing analysts’ consensus estimates of $2.98 by ($0.38). The company had revenue of $6.02 billion for the quarter, compared to analysts’ expectations of $6.34 billion. Stryker had a net margin of 13.20% and a return on equity of 23.42%. The business’s revenue for the quarter was up 2.6% compared to the same quarter last year. During the same period last year, the company posted $2.84 EPS. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. Equities research analysts predict that Stryker Corporation will post 14.98 earnings per share for the current year.

Stryker Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Tuesday, June 30th will be paid a dividend of $0.88 per share. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date of this dividend is Tuesday, June 30th. Stryker’s dividend payout ratio is 40.74%.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.